<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet title="XSL_formatting" type="text/xsl" href="/i/xml/xsl_formatting_rss.xml"?>
<rss version="2.0" xmlns:blogChannel="http://backend.userland.com/blogChannelModule">

<channel>
<title>SkyePharma PLC News</title>
<link>http://www.iii.co.uk/investment/detail?code=cotn:SKP.L&amp;display=news</link>
<description></description>

<item>
<title>Skyepharma PLC - NEW ORAL DEVELOPMENT ORGANISATION</title>
<link>http://www.iii.co.uk/investment/detail?code=cotn:SKP.L&amp;display=news&amp;action=article&amp;articleid=8491719&amp;from=rss</link>
<description>RNS Number : 9962WSkyepharma PLC08 February 2012 

   &#65279;

    IMPLEMENTATION OF NEW ORAL DEVELOPMENT ORGANISATION

   Agreement maintains SkyePharma's innovative oral drug delivery
   capabilities

    

   LONDON, UK, 8 February, 2012 - SkyePharma PLC (LSE: SKP) today
   announces that, further...</description>
<pubDate>Wed, 08 Feb 2012 09:00:00 GMT</pubDate>
</item>

<item>
<title>Skyepharma PLC - Director/PDMR Shareholding</title>
<link>http://www.iii.co.uk/investment/detail?code=cotn:SKP.L&amp;display=news&amp;action=article&amp;articleid=8488640&amp;from=rss</link>
<description>RNS Number : 8162WSkyepharma PLC03 February 2012 

   &#65279;

   [TABLE NOT SHOWN]

    

   SkyePharma PLC ("the Company")

    

   The Company was informed on 3 February 2012 that as a result of
   transactions on 31 January 2012 by the SkyePharma PLC Share Purchase
   Plan (the "Plan") (an approved...</description>
<pubDate>Fri, 03 Feb 2012 17:28:00 GMT</pubDate>
</item>

<item>
<title>Skyepharma PLC - Directorate Change</title>
<link>http://www.iii.co.uk/investment/detail?code=cotn:SKP.L&amp;display=news&amp;action=article&amp;articleid=8483340&amp;from=rss</link>
<description>RNS Number : 4334WSkyepharma PLC31 January 2012 

   &#65279;

   Directorate Change

    

   LONDON, UK, 31st  January, 2012 - SkyePharma PLC (LSE: SKP) today
   announces that Axel Mueller has resigned as Chief Executive Officer
   and a director of SkyePharma PLC with immediate effect to pursue other
...</description>
<pubDate>Tue, 31 Jan 2012 08:30:00 GMT</pubDate>
</item>

<item>
<title>Skyepharma PLC - Director/PDMR Shareholding</title>
<link>http://www.iii.co.uk/investment/detail?code=cotn:SKP.L&amp;display=news&amp;action=article&amp;articleid=8465368&amp;from=rss</link>
<description>RNS Number : 3075VSkyepharma PLC10 January 2012 

   &#65279;

   [TABLE NOT SHOWN]

    

   SkyePharma PLC ("the Company")

    

   The Company was informed on 10 January 2012 that as a result of
   transactions on 30 December 2011 by the SkyePharma PLC Share Purchase
   Plan (the "Plan") (an approved...</description>
<pubDate>Tue, 10 Jan 2012 12:32:00 GMT</pubDate>
</item>

<item>
<title>Skyepharma PLC - Reorganisation of Swiss Operations</title>
<link>http://www.iii.co.uk/investment/detail?code=cotn:SKP.L&amp;display=news&amp;action=article&amp;articleid=8465038&amp;from=rss</link>
<description>RNS Number : 2781VSkyepharma PLC10 January 2012 

   &#65279;

   SKYEPHARMA PLC - REORGANISATION OF SWISS OPERATIONS

    

   LONDON, UK, 10 January, 2012 - SkyePharma PLC (LSE: SKP) today
   announces that the SkyePharma Group ("SkyePharma") has entered into a
   consultation process which could lead...</description>
<pubDate>Tue, 10 Jan 2012 09:21:00 GMT</pubDate>
</item>

<item>
<title>Skyepharma PLC - Product Update</title>
<link>http://www.iii.co.uk/investment/detail?code=cotn:SKP.L&amp;display=news&amp;action=article&amp;articleid=8453061&amp;from=rss</link>
<description>RNS Number : 5691USkyepharma PLC23 December 2011 

   &#65279;

   SKYEPHARMA PLC - UPDATE ON FLUTIFORM&#8482; EUROPE

    

   LONDON, UK, 23 December 2011 -  SkyePharma PLC (LSE: SKP) today
   announces that the decentralised procedure ("DCP") for the regulatory
   review of Flutiform&#8482; has been...</description>
<pubDate>Fri, 23 Dec 2011 07:00:00 GMT</pubDate>
</item>

<item>
<title>Skyepharma PLC - Director Declaration</title>
<link>http://www.iii.co.uk/investment/detail?code=cotn:SKP.L&amp;display=news&amp;action=article&amp;articleid=8441626&amp;from=rss</link>
<description>RNS Number : 8219TSkyepharma PLC12 December 2011 

   &#65279;

    

    

    

    

    

    

   SkyePharma Announces Change in Director's Details

    

   LONDON, UK, 12 December, 2011 - SkyePharma PLC (LSE: SKP) today
   announces in accordance with Listing Rule 9.6.14R, that Dr Thomas
   Werner,...</description>
<pubDate>Mon, 12 Dec 2011 17:09:00 GMT</pubDate>
</item>

<item>
<title>Skyepharma PLC - Director/PDMR Shareholding</title>
<link>http://www.iii.co.uk/investment/detail?code=cotn:SKP.L&amp;display=news&amp;action=article&amp;articleid=8441488&amp;from=rss</link>
<description>RNS Number : 8118TSkyepharma PLC12 December 2011 

   &#65279;

   [TABLE NOT SHOWN]

    

   SkyePharma PLC ("the Company")

    

   The Company was informed on 9 December 2011 that as a result of
   transactions on 30 November 2011 by the SkyePharma PLC Share Purchase
   Plan (the "Plan") (an approved...</description>
<pubDate>Mon, 12 Dec 2011 15:39:00 GMT</pubDate>
</item>

<item>
<title>Skyepharma PLC - Regulatory Application</title>
<link>http://www.iii.co.uk/investment/detail?code=cotn:SKP.L&amp;display=news&amp;action=article&amp;articleid=8428737&amp;from=rss</link>
<description>RNS Number : 9718SSkyepharma PLC29 November 2011 

   FDA Accepts Lodotra® New Drug Application for Review

   Review Scheduled to be Completed in H2 2012

    

    

   LONDON, UK, 29 November, 2011 &#8211; SkyePharma PLC (LSE: SKP) today
   announces that the United States Food and Drug Administration
...</description>
<pubDate>Tue, 29 Nov 2011 12:16:00 GMT</pubDate>
</item>

<item>
<title>Skyepharma PLC - Interim Management Statement</title>
<link>http://www.iii.co.uk/investment/detail?code=cotn:SKP.L&amp;display=news&amp;action=article&amp;articleid=8413519&amp;from=rss</link>
<description>RNS Number : 0147SSkyepharma PLC14 November 2011 

   &#65279;

   SKYEPHARMA PLC - INTERIM MANAGEMENT STATEMENT

    

   LONDON, UK, 14 November 2011 -  SkyePharma PLC (LSE: SKP) today
   publishes its Interim Management Statement for the period 1 July 2011
   to 13 November 2011 and provides an update...</description>
<pubDate>Mon, 14 Nov 2011 07:00:00 GMT</pubDate>
</item>

</channel>
</rss>
